These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31207391)

  • 1. Predictive factors associated with involved margins in breast cancer treated with neoadjuvant chemotherapy followed by breast-conserving therapy.
    Davoine E; Dion L; Nyangoh Timoh K; Beraud E; Tas P; Tavenard A; Laviolle B; Perrin C; Foucher F; Levêque J; Lavoué V
    J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):467-472. PubMed ID: 31207391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
    Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
    J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
    Di Lena É; Iny E; Wong SM; Bassel M; Shah A; Basik M; Boileau JF; Martel K; Meterissian S; Prakash I
    Ann Surg Oncol; 2024 Oct; 31(10):6786-6794. PubMed ID: 38969849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in breast-conserving surgery - Consequences on margin status and excision volumes: A nationwide pathology study.
    Volders JH; Haloua MH; Krekel NM; Negenborn VL; Barbé E; Sietses C; Jóźwiak K; Meijer S; van den Tol MP;
    Eur J Surg Oncol; 2016 Jul; 42(7):986-93. PubMed ID: 27211343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of margin status after breast-conserving operations in an underscreened population.
    Torabi R; Hsu CH; Patel PN; Dave H; Bouton ME; Komenaka IK
    Langenbecks Arch Surg; 2013 Mar; 398(3):455-62. PubMed ID: 23184267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy.
    Lin J; Lin KJ; Wang YF; Huang LH; Chen SL; Chen DR
    BMC Cancer; 2020 May; 20(1):451. PubMed ID: 32434493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for positive margins in conservative surgery for breast cancer after neoadjuvant chemotherapy.
    Bouzón A; Acea B; García A; Iglesias Á; Mosquera J; Santiago P; Seoane T
    Cir Esp; 2016; 94(7):379-84. PubMed ID: 27158077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
    Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
    Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
    van Deurzen CH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery.
    Cen C; Chun J; Kaplowitz E; Axelrod D; Shapiro R; Guth A; Schnabel F
    Ann Surg Oncol; 2021 Sep; 28(9):5142-5148. PubMed ID: 33635409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy.
    Ploumen RAW; Claassens EL; Kooreman LFS; Keymeulen KBMI; van Kats MACE; van Kuijk SMJ; Siesling S; van Nijnatten TJA; Smidt ML
    Eur J Surg Oncol; 2024 Sep; 50(9):108465. PubMed ID: 38870869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome.
    van Hemert A; van Loevezijn AA; Bosman A; Vlahu CA; Loo CE; Peeters MTFDV; van Duijnhoven FH; van der Ploeg IMC
    Breast Cancer Res Treat; 2024 Apr; 204(3):497-507. PubMed ID: 38189904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy.
    Mazouni C; Naveau A; Kane A; Dunant A; Garbay JR; Leymarie N; Sarfati B; Delaloge S; Rimareix F
    Breast; 2013 Dec; 22(6):1189-93. PubMed ID: 24054903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.
    Spronk PER; Volders JH; van den Tol P; Smorenburg CH; Vrancken Peeters MTFD
    Eur J Surg Oncol; 2019 Feb; 45(2):110-117. PubMed ID: 30348601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.
    Mombelli S; Kwiatkowski F; Abrial C; Wang-Lopez Q; de Boissieu P; Garbar C; Bensussan A; Curé H
    Oncology; 2015; 88(5):261-72. PubMed ID: 25573741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome.
    Karanlik H; Ozgur I; Cabioglu N; Sen F; Erturk K; Kilic B; Onder S; Deniz M; Yavuz E; Aydiner A
    Eur J Surg Oncol; 2015 Sep; 41(9):1226-33. PubMed ID: 26141784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response].
    Brisson C; Diguisto C; Vildé A; Body G; Arbion F; Leveque J; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):147-154. PubMed ID: 28403971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.